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Panton–Valentine Leukocidin 
Colocalizes with Retinal Ganglion 
and Amacrine Cells and Activates 
Glial Reactions and Microglial 
Apoptosis
XuanLi Liu1, Pauline Heitz2, Michel Roux  3, Daniel Keller1, Tristan Bourcier1,2, Arnaud Sauer2, 
Gilles Prévost1 & David Gaucher1,2
Experimental models have established Panton–Valentine leukocidin (PVL) as a potential critical 
virulence factor during Staphylococcus aureus endophthalmitis. In the present study, we aimed to 
identify retinal cell targets for PVL and to analyze early retinal changes during infection. After the 
intravitreous injection of PVL, adult rabbits were euthanized at different time points (30 min, 1, 2, 4 and 
8 h). PVL location in the retina, expression of its binding receptor C5a receptor (C5aR), and changes in 
Müller and microglial cells were analyzed using immunohistochemistry, Western blotting and RT-qPCR. 
In this model of PVL eye intoxication, only retinal ganglion cells (RGCs) expressed C5aR, and PVL was 
identified on the surface of two kinds of retinal neural cells. PVL-linked fluorescence increased in RGCs 
over time, reaching 98% of all RGCs 2 h after PVL injection. However, displaced amacrine cells (DACs) 
transiently colocalized with PVL. Müller and microglial cells were increasingly activated after injection 
over time. IL-6 expression in retina increased and some microglial cells underwent apoptosis 4 h and 8 h 
after PVL infection, probably because of abnormal nitrotyrosine production in the retina.
Bacterial endophthalmitis is a common but severe infection of the eye, which is often caused by ocular surgery or 
trauma1. The visual prognosis of endophthalmitis depends on many factors, one of the most important being the 
virulence of the infecting bacteria, as reported in a recent study2. Though Staphylococcus aureus is rarely involved 
in ocular endophthalmitis, it secretes an extensive repertoire of cytotoxins that represent a significant threat to 
visual outcomes.
Methicillin-resistant S. aureus (MRSA) places a significant burden on healthcare resources due to its resistance 
to antimicrobial treatment. Community-associated (CA)-MRSA, which emerged in 1990s, can be distinguished 
from hospital-acquired (HC)-MRSA, primarily because it bears the gene encoding Panton–Valentine leukocidin 
(PVL)3,4. Recent studies have reported that the percentage of CA-MRSA has significantly increased in MRSA 
infection isolates and may continue to rise in the future due to the horizontal transfer of genes and inter-human 
transmission5. PVL is composed of two distinct proteins, a class S (31–32 kDa) and a class F component (33–
34 kDa), which organize as alternate octamers, called prepores, and are internalized into polymorphonuclear cells 
where they initiate intracellular relapsing of Ca2+ storages. The class S component binds to the C5a membrane 
receptor (C5aR), allowing the secondary interaction of the F component. Unaccompanied class S or F proteins 
never seem to produce any effect on targeted cells6. PVL may result in tissue necrosis during S. aureus infection, 
especially necrotizing infections, such as furuncles, acute necrotizing pneumonia, and osteomyelitis7,8.
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Recent studies have reported that PVL binds to human complement C5a receptor. This binding largely 
decreases in rodents but is conserved in rabbits9. Recent studies on humanized mice with C5aR showed the crit-
ical role played by PVL in the determination of necrotizing pneumonia and its severity10,11. Other staphylococcal 
leukotoxins have been characterized, but only LukS-PV and HlgC were shown to bind C5aR10,11. There has been 
evidence of PVL targeting myeloid cells such as monocytes (M), macrophages (Mφ), and polymorphonuclear 
cells (PMNs), but not lymphocytes12. Another recent study showed that in vitro, PVL could target dorsal root 
neurons and cerebellum granular neurons13. In the rabbit eye, previous studies revealed that PVL and other 
staphylococcal leukotoxins injected into the rabbit vitreous could cause retinal inflammation and breakdown of 
the blood–retinal barrier (BRB)14,15. However, the mechanism leading to such inflammation remains to be deter-
mined albeit vitreous is mainly devoid of cells.
IL-6 has been shown to have effective angiogenic activities and inflammatory role in models of choroidal 
neovascularization, ocular inflammation and tumor angiogenesis16. In this study, our purpose was to identify 
retinal cell targets for PVL and to analyze initial mechanisms that might support or indicate inflammation and 
inter-cellular communication. In particular, we studied the potential consequences of retinal cell infection, such 
as glial reaction, neuronal cell damage, and the presence of inflammatory markers. The results reported herein 
strongly suggest that PVL colocalized with two types of retinal neurons: displaced amacrine cells (DACs) very 
early in the translocation process, and retinal ganglion cells (RGCs), which triggered a glial reaction and an 
increase of IL-6 expression in the retina.
Results
PVL was located in RGCs and DACs. An anti-LukS-PV antibody (Table 1) was used to identify PVL 
translocation from the rabbit vitreous into the retina. Results indicated that PVL was concentrated in the ganglion 
cell layer. Since this cell layer is composed of RGCs and DACs, we investigated the exact target of PVL using spe-
cific labeling for RGCs (anti-RBPMS antibody) and DACs (anti-CHAT antibody) (Table 1).
RGCs were PVL-positive. The rate of positive RGCs significantly increased from 47% to 76% from 30 min to 
1 h (p < 0.05) after PVL injection. This rate reached 98% after 2 h (p < 0.05 compared with the rate of 1 h) and 99% 
4 h after PVL injection (Fig. 1). The majority of DACs were PVL-positive at 30 min after PVL injection. However, 
the rate of PVL-positive DACs significantly decreased from 68% to 32% between 30 min and 1 h (p < 0.01) after 
PVL injection, respectively. This rate continued to significantly decrease and was 27% at 2 h and 5% at 4 h follow-
ing PVL injection (p < 0.01) (Fig. 2). Eight hours after PVL injection, all RGCs colocalized with PVL, while 4% of 
DACs still colocalized with PVL (see Supplementary Fig. S1).
To further investigate whether PVL was specifically colocalized with the RGCs and DACs, we examined the 
rabbit retina for C5aR and C5L2 expression using specific antibodies, since PVL binds with human neutrophils 
through the C5a receptor9,17. The anti-C5L2 antibody did not detect any specific staining in rabbit retina (Fig. 3G). 
C5aR was consistently expressed in RGCs suggesting that PVL might colocalize with RGCs through C5aR. C5aR 
did not colocalize with DACs (Fig. 3 and Table 1). Therefore, another mechanism for PVL colocalization (possibly 
with a decreased affinity) and possible penetration in DACs cannot be excluded.
The Müller and microglial cells were activated after PVL injection. Müller cells can transform into 
an activated state, characterized by the rapid upregulation of glial fibrillary acidic protein (GFAP). This upregu-
lation occurs after acute retinal injuries or inflammation states18. Anti-GFAP antibody was used to label Müller 
cells (Table 1). As early as 30 min after PVL injection, Müller cells abnormally expressed GFAP in the outer retina 
(Fig. 4 and Table 1). This abnormal GFAP expression was not observed in the controls. Only a few Müller cell 
processes stained with GFAP were visible in the outer retina at 30 min, whereas the number and extension of 
processes increased from 1 to 2 h after PVL injection. At these time points, the outer plexiform layer (OPL) was 
well defined with GFAP staining. At 4 h, it seemed that the architecture of the retina had changed as numerous 
disruptions of GFAP staining within outer processes and the OPL were noticed (Fig. 4). These disruptions were 
not detected at earlier time points (Fig. 4).
Morphological changes of Cy3-tagged GSAI-B4 labeled microglial cells (Table 1) were observed 2 h follow-
ing PVL injection. The cell bodies and dendrites were enlarged, and the number of dendritic processes clearly 
decreased, which may correspond to an early activation state19. After 4 h, the microglial dendritic processes dis-
appeared. However, no apparent microglial cell migration across the retina was observed on vertical sections 
(Fig. 5).
Some retinal microglial cells underwent apoptosis. Terminal deoxynucleotidyl transferase dUTP 
nick-end labeling (TUNEL)-positive cells were located in the inner plexiform layer and ganglion cell layer 4 h 
and 8 h after PVL injection (Fig. 6A,B), while TUNEL were negative in control retinas and PVL injected reti-
nas at 30 min, 1 h, 2 h time points retinas (see Supplementary Fig. S2). TUNEL-positive cells did not colocalize 
with either RBPMS-immunoreactive RGCs or CHAT-immunoreactive DACs (see Supplementary Fig. S3 and 
Table 1). Only microglial cells colocalized with TUNEL-positive cells, as shown in Fig. 6. At 4 h, the mean num-
ber of TUNEL-positive cells/field was 1.06. At 8 h, the number of apoptotic cells increased: mean number of 
TUNEL-positive cells/field was 1.86.
IL-6 and nitrotyrosine inflammation markers increased 4 h and 8 h after PVL injection. The 
immunohistochemistry staining of nitrotyrosine 4 h and 8 h after PVL injection showed increased nitrotyros-
ine accumulation in the retina compared with the controls (Fig. 6F,G,H). The nitrotyrosine-modified proteins 
increased by almost two times in PVL-treated retinas after 4 h compared with the controls, as demonstrated by 
Western blotting (Fig. 6I,J). Nitrotyrosine is a stable marker of peroxynitrite-mediated oxidative damage, which 
is indicative of nitric oxide (NO) production in the retina after PVL injection.
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RT-qPCR test revealed that IL-6 mRNA significantly increased in retinal tissue by 11.24 folds and 13.74 folds 
at 4 and 8 h respectively after PVL injection compared to controls (Fig. 7A). Semi-quantitative analysis of western 
blot results showed that IL-6 proteins expression in retinal tissue was also increased by 1.85 folds at 4 h and 2.87 
folds at 8 h after PVL injection compared to controls (Fig. 7B). mRNA and protein expression of other inflam-
matory factors such as IL-8, TNFα, IL-1β, VEGF MCP-1 were also measured by RT-qPCR and western blot. But 
no significant difference, albeit variations, were noted between controls and PVL infected retinas (Fig. 7A and 
Supplementary Fig. S4).
Discussion
PVL colocalizes with RGCs through C5aR and transiently colocalizes with DACs through an unknown mecha-
nism in the rabbit retina. Müller and microglial cells are activated after that PVL colocalizes with both RGC and 
DAC neural cells.
The exact mechanism by which neural cells are activated remains unknown. A recent report established that 
LukS-PV can bind C5aR and C5L2, the two complement C5a receptors, to mediate the toxin binding and tox-
icity in rabbit and human blood cells9. C5a receptors are abundantly expressed in myeloid cells, but they are 
less expressed in non-myeloid cells. Neural cells have been identified to express functional complement C5a 
receptors20. In general, we consider that C5aR is the major receptor and C5L2 is the minor receptor for C5a, and 
possibly for PVL. C5L2 is an intracytoplasmic G-protein-coupled receptor, never present at the cell membrane. 
C5L2 does not couple with G proteins, is not found to have a direct signaling function21, and is not identified in 
any neurons. In addition, the quantity of mRNA and protein of C5L2 are significantly lower than those of C5aR in 
leukocytes, although C5L2 has nearly similar affinity to LukS-PV as C5aR in U937 C5aR-transfected cells22. The 
findings of the present study confirm the presence of C5aR but not of C5L2 in the rabbit retina. C5aR expression 
in the retina is demonstrated before: one report detected the presence of C5aR in the inner plexiform layer and 
occasionally in the ganglion cell layer in human retina23, and another report showed that C5aR was expressed in 
the ganglion cell layer of mouse retina24. There are two kinds of cells in the ganglion cell layers: RGCs and DACs. 
Neither of the two reports could distinguish whether only one of them expresses C5aR. Finally, another report 
showed that retinal Müller cells could also express C5aR (in vitro)25. In the present study, only RGCs expressed 
C5aR. As PVL concentrates in RGCs and RGCs express C5aR (Fig. 3), we believe that PVL colocalizes with RGCs 
through C5aR.
DACs did not express C5aR, but they were transiently colocalized with PVL. Although it was shown that 
LukS-PV is unable to bind any blood cells without C5aR, all these studies investigated myeloid cells only9. The 
Primary antibodies or lectin
Target Antiserum Source Concentration
PVL Rabbit anti-LukS-PV polyclonal EA-7290, Strasbourg, France 2 µg/mL
C5aR Rabbit anti-C5aR polyclonal Abcam, Cambridge, UK 2 µg/mL
Ganglion cells Guinea pig anti-RBPMS polyclonal UCLA Neurobiology, Los Angeles, CA, USA 2 µg/mL
Displaced amacrine cells Goat anti-CHAT polyclonal Chemicon Merck-Millipore, Temecula, CA, USA 20 µg/mL
Müller cells Mouse anti-GFAP polyclonal Bio-Rad AbD Serotec, Oxfordshire, UK 2 µg/mL
Microglial cells Cy3-tagged GSAI-B4 Sigma Aldrich, Saint Louis, MO, USA 2 µg/mL
Nitrotyrosine Mouse anti-nitrotyrosine monoclonal Santa Cruz Biotechnology, Heidelberg, Germany 2 µg/mL
C5L2 Rabbit anti-C5L2 polyclonal GeneTex, San Antonio, TX, USA 2 µg/mL
β-actin Rabbit anti-β-actin polyclonal Santa Cruz Biotechnology, Heidelberg, Germany 1:2000
IL-6 Mouse anti-IL-6 monoclonal Abbexa Ltd, Cambridge, UK 1:2000
IL-8 Mouse anti IL-8 monoclonal Abbexa Ltd, Cambridge, UK 1:2000
IL-1β Rabbit anti-IL-1β polyclonal Abbexa Ltd, Cambridge, UK 1:2000
TNF-α Mouse anti-TNFα monoclonal Abbexa Ltd, Cambridge, UK 1:2000
Secondary antibodies
Anti-rabbit Goat and donkey polyclonal Alexa 555 nm-conjugated Life Technologies, Carlsbad, CA, USA 2 µg/mL
Anti-goat Donkey polyclonal Alexa 488-conjugated Molecular Probes, Eugene, OR, USA 2 µg/mL
Anti-mouse Donkey polyclonal Alexa 488-conjugated Abcam 2 µg/mL
Anti-guinea pig Goat polyclonal Alexa 488-conjugated Abcam 2 µg/mL
TUNEL DNA strand breaks Roche Life Science, Indianapolis, IN, USA —
Nuclei Hoechst 33258 Molecular ProbesTM, Eugene, OR, USA 0.1 µg/mL
Anti-rabbit Anti-Rabbit IgG (whole molecule)–Peroxidase Sigma Aldrich, Saint Louis, MO, USA 1:10000
Anti-mouse Goat anti-mouse IgG-Peroxidase Santa Cruz Biotechnology, Heidelberg, Germany 1:10000
Table 1. list of Specific markers used in the current study. RBPM, RNA-binding protein with multiple splicing; 
CHAT, choline acetyl transferase; GFAP, glial fibrillary acidic protein; GSAI, Griffonia simplicifolia agglutinin 
isolectin. TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labelling.
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sensitivity of neurons to PVL was first addressed by Jover et al., who demonstrated the neurotoxic activity of HlgC/B 
and PVL13. Given that DACs are neurons, we cannot exclude the possibility of another PVL-binding mechanism
PVL concentration increased in RGCs with time, while PVL expression decreased in DACs within a few 
hours. The diverse kinetics of PVL association with RGCs and DACs is difficult to explain apart from another 
specificity for an eventual second receptor. RGCs are long-projection neurons and may establish links with other 
cells such as DACS and microglia or other glial cells. They send visual information through their long axons 
from the retina to the brain26. DACs are integrated interneurons without axons. Because they are located at the 
second synaptic level of light pathways, consisting of the photoreceptor-bipolar-ganglion cell chain, DACs play 
the role of modulating and interposing the signal transmitter27. Compared to RGCs, DACs are more resistant 
Figure 1. PVL expression in RGCs. PVL (red fluorescence A,D,G,J) colocalized with RGCs labeled with 
anti-RBPMS antibody (green fluorescence B,E,H,K) in the retinal vertical sections 30 min (A–C), 1 h (D–F), 
2 h (G–I), and 4 h (J–L) after PVL injection. The number of PVL-positive RGCs increased with time (C,F,I,L 
yellow fluorescence), the rate of PVL-positive RGCs were 47%, 76%, 98%, 99% for 30 min and 1, 2, and 4 h 
(M, ***p < 0.001, *p < 0.05 n = 3 eyes at each time point). Abbreviated symbols: PVL, Panton–Valentine 
leukocidin; RGCs, retinal ganglion cells; RBPMS, RNA-binding protein with multiple splicing; GCL, ganglion 
cell layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS, photoreceptor 
outer segments.
www.nature.com/scientificreports/
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to neurodegeneration than RGCs after glaucoma and complete optic nerve transection28. Some selective RGCs 
may be postsynaptic to DACs29. However, little is known about the other relationships between RGCs and DACs.
Laventie et al. injected PVL and antibodies against S or/and F component in rabbit vitreous for 24 h29. The 
animal groups with humanised antibodies against either S or F component along PVL injection did not show a 
significant ocular inflammation, while the group injected with only PVL showed a great ocular inflammation. 
In this work, it was demonstrated that both the S and F components of leukotoxins were necessary to cause a 
physiological response29. Through the possible C5aR binding, PVL could initiate the rise of intracellular Ca2+ 
concentration and the release of glutamate, as was recently shown in newborn rat cerebellar granular neurons13. 
The rise of Ca2+ concentration can activate some signal pathways to produce pro-inflammatory cytokines, chem-
otaxis or neurotransmitters in neurons and initiate inflammation30–32. Chiu et al. showed that bacteria secrete 
Figure 2. PVL expression was transient in DACs. Thirty minutes after PVL injection, the majority of DACs 
labeled with anti-CHAT antibody (green fluorescence B,C) colocalized with PVL (red fluorescence A,C). 
After 1 h, the PVL-positive DACs decreased (D–L). The percentage of PVL-positive DACs were 68%, 32%, 
27%, 5% for 30 min and 1, 2, and 4 h (M, ***p < 0.001, *p < 0.05, n = 3 eyes at each time point). Abbreviated 
symbols: PVL, Panton–Valentine leukocidin; DACs, displaced amacrine cells; CHAT, choline acetyl transferase; 
GCL, ganglion cell layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS, 
photoreceptor outer segments.
www.nature.com/scientificreports/
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N-formylated peptides and α-hemolysin, which directly induce calcium flux and action potentials through noci-
ceptors at the end of sensory neurons33, resulting in the release of neuropeptides and neurogenic inflammation34.
The morphological changes in Müller and microglial cells were observed in this study at 30 min and 2 h 
respective after PVL injection. We found elevated inflammatory markers at 4 h post-PVL injection. It is difficult 
to deduce whether the activated glial cells are a consequence or a cause of neural dysfunction. Indeed, when the 
neuron system is subjected to injury due to inflammation or trauma the glial cells are activated and exhibit glio-
sis18. Activated Müller cells can disturb the structural support or metabolic function of neurons, resulting in their 
dysfunction and loss. The activated microglia can also modulate the expression of trophic factors by Müller cells, 
which indirectly affects photoreceptors35,36. However, in this study, we could not detect any neuronal damage at 
least until 8 h after PVL injection.
Nitrotyrosine represents reactive oxygen species and reactive nitrogen species, which have diffused in the ret-
inal tissue37. Increased nitrotyrosine concentration reflects an underlying inflammatory process with significant 
NO production, and this was observed in the retinal tissue as early as 4 h after PVL injection. It has established 
that NO can downregulate the tight junction proteins occludin and ZO-1, resulting in the breakdown of the 
BRB38. The state of microglial cell activation is conversely correlated with cell viability. In a recent study, apoptosis 
of in vitro activated microglial cells was promoted by NO production. Indeed, microglial cells can produce NO 
and undergo apoptotic death when they are significantly activated39. As our study showed that some microglial 
Figure 3. C5aR was expressed by RGCs. Double-labeling immunohistochemistry in the control eyes showed 
that RGCs labeled with anti-RBPMS antibody (green fluorescence A,C) colocalized with anti-C5aR staining 
(red fluorescence B,C), and the DACs labeled with anti-CHAT antibody (green fluorescence E,F) did not 
colocalize with anti-C5aR staining (red fluorescence D,F). The anti-C5L2 labeling did not show specific staining 
in retina (red fluorescence G). Abbreviated symbols: RGCs, retinal ganglion cells; RBPMS, RNA-binding 
protein with multiple splicing; DACs, displaced amacrine cells; CHAT, choline acetyl transferase; GCL, ganglion 
cell layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS, photoreceptor 
outer segments.
www.nature.com/scientificreports/
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cells underwent apoptotic death and nitrotyrosine concentration increased 4 h after PVL injection, there might 
be a significant correlation between NO production, microglial cell apoptosis, and retinal inflammation during 
PVL infection.
IL-6 interacts with its receptor and then elicits JAK/STAT (Janus kinase/signal transducer and activator of 
transcription) and MAPK (mitogen-activated protein kinase) pathways which enhance numerous biological 
activities40. IL-6 was proved to be associated to many ocular pathologies related to inflammations, such as uve-
itis, glaucoma, ocular neovascularization and autoimmune disease16. The humanized anti-human IL-6R mAb, 
Tocilizumab, is effective to treat refractory uveitis and potent new therapeutic for other ocular diseases41. Rojas et 
al. proved that intravitreal injection of angiotensin II caused increases of IL-6 mRNA and protein. IL-6 was local-
ized to retinal microglia and/or macrophages42. The present study showed that IL-6 mRNA and protein in retina 
increased after 4 h and 8 h PVL injection. The increased IL-6 expression might be due to activated microglial cells 
and may play a great role in nitrotyrosine production and retinal inflammation.
Figure 4. Müller cell reactivity was observed as early as 30 min after PVL injection. Compared with control eyes 
(green fluorescence A), anti-GFAP labeling was abnormally present in outer retina in PVL-injected eyes (green 
fluorescence B–E). More anti-GFAP-stained Müller processes (arrows) were noted at 1 h (C), 2 h (D), and 4 h 
(E) than at 30 min after PVL injection. At 1 h and 2 h, OPL was well defined with GFAP staining (arrowheads). 
At 4 h, disruptions of GFAP staining within outer processes and the OPL were noticed (arrowheads). (n = 3 eyes 
at each time point). Abbreviated symbols: GFAP, glial fibrillary acidic protein; OPL, outer plexiform layer; ONL, 
outer nuclear layer; OS, photoreceptor outer segments.
Figure 5. The microglial cells underwent morphological changes 2 h after PVL injection. (A–C) were vertical 
retinal sections, while (D–F) were whole retinal mounts. Cy3-tagged GSAI-B4 labeled microglial cell. Hoechst 
stained nuclei (blue fluorescence A-C). No microglial cell migration was observed (green fluorescence A–C). 
However, microglial cells showed retracted dendrites (arrow) and enlarged proximal parts of processes 
(arrowhead) (green fluorescence B,E) compared to controls (green fluorescence A,D). After 4 h, the microglial 
processes disappeared (arrow) (green fluorescence C,F). (n = 3 eyes at each time point). Abbreviated symbols: 
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer.
www.nature.com/scientificreports/
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Nevertheless, early activation of Müller and microglial cells may cause major consequences to the visual out-
comes in this PVL-mediated endophthalmitis model14. Further investigations of the effects of PVL binding on neu-
ral activity and the relation between neurogenic inflammation and glial cell activation should be performed. Retinal 
explants and in situ sophisticated approaches might bring more insights about the sequential activity of retinal cells.
Materials and Methods
Animal and surgical procedure. The animal experiments were approved by the Ministère de l’Education 
nationale, de l’Enseignement supérieur et de la Recherche, France (APAFiS no. 4986). The surgical procedure 
was performed in accordance with the guidelines in the laboratory of the Association for Research in Vision 
and Ophthalmology within the accredited A67-482-34 and B67-482-34 animal facilities. Nine pigmented rabbits 
(Bleu de Champagne) aged one year and weighing 3.5–4 kg were anesthetized by a lumbar intramuscular injec-
tion of ketamine, 20 mg/kg (Virbac, Carros, France) and xylazine, 3 mg/kg (Bayer Healthcare, Puteaux, France). 
After local anesthesia of the eyeball with 2–3 drops of oxybuprocaine chlorhydrate (Théa, Clermont-Ferrand, 
France), PVL in phosphate-buffered saline (PBS) (3 µg/50 µL), purified from ATCC49775 S. aureus43, was intra-
vitreally injected with a 30-Gauge needle inserted 4 mm behind the corneal limbus. For controls, three eyes were 
injected with 50-µL PBS using the same technique. After PVL injection, animals were sacrificed at 30 min, 1, 2 
Figure 6. Some microglial cells underwent apoptosis, nitrotyrosine accumulated in the retina 4 h and 8 h after 
PVL injection. Apoptotic cells were situated in inner retina at 4 h (arrow head, red fluorescence A) and 8 h 
(arrow head, red fluorescence B) after PVL injection. The TUNEL-positive cells (arrow head, red fluorescence 
D,E) colocalized with microglial cells (arrow, green fluorescence C,E). Hoechst stained nuclei (blue fluorescence 
A,B,D,E). RGCs and DACs did not colocalize with TUNEL-positive cells (Supplementary Fig. S3). The immune 
activity of nitrotyrosine increased in the retina 4 h (red fluorescence G) and 8 h (red fluorescence H) after PVL 
injection compared with controls (red fluorescence F). Western blotting experiments showed that nitrotyrosine-
modified proteins were expressed (migration of bands between 37 to 75 kDa) in both PVL-treated 4 h retinas 
and controls. The full-length blots are presented in Supplementary Fig. S5. Nitrotyrosine and β-acitin blot were 
from the same samples in the same gel (I). However, the total intensity of bands quantified by densitometry 
was increased almost two times in PVL-treated 4 h retinas compared to controls. (I,J). (**p < 0.01, n = 3 eyes). 
Abbreviated symbols: TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labeling; RGCs, retinal 
ganglion cells; DACs, displaced amacrine cells. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner 
nuclear layer; ONL, outer nuclear layer; OS, photoreceptor outer segments. ns: no significant difference.
www.nature.com/scientificreports/
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and 4 h (two animals: three eyes with PVL and one control eye in each group) first using anesthesia with keta-
mine-xylazine (as mentioned above), followed by a lethal intravenous injection of 2-mL Pentobarbital Dolethal® 
(Vetoquinol, Lure, France) through a 22-Gauge catheter inserted in the marginal auricular vein.
Eye preparation. The eyes were intravitreally injected with 100 μL of 4% (wt/vol) paraformaldehyde 
(Thermo Fisher Scientific, Rockford, IL, USA) immediately after sacrifice, and were then oriented and enucle-
ated. The cornea, iris, and crystalline lens were immediately removed. Half of the eye globe was fixed for 3 h in 4% 
paraformaldehyde, and the remainder was immediately frozen. The dissected eyes were successively immersed 
in 10% (wt/vol) and 20% (wt/vol) sucrose and stored in 30% (wt/vol) sucrose overnight at 4 °C. For a better cry-
osection, the retina was separated from the pigmented epithelium. The temporal zone of 1–5 mm near the optic 
disc was isolated and then immersed in optimal cutting temperature compound (Sakura Finetek, Torrance, CA, 
USA). Vertical cryostat 8-µm-thick sections were mounted on a Super FrostTM Plus microscope slides (Thermo 
Fisher Scientific, Rockford, IL, USA) and stored at −20 °C.
Immunohistochemistry. Immunohistochemistry was performed to analyze the retinal cells targeted by 
PVL. PVL protein was stained using anti-LukS-PV-specific antibody. Retinal sections and whole mounts were 
permeabilized in 0.05% (v/v) and 0.1% (v/v) TritonX-100, respectively, for 1 h and then were blocked with 10% 
(v/v) donkey or goat serum (Sigma-Aldrich, St. Louis, MO, USA) for 1 h. Retinal sections were incubated with 
primary antibody (see Table 1 for details) at 4 °C overnight in a humidity chamber. Retinal sections were then 
incubated for 1 h at room temperature with fluorescent secondary antibodies or TUNEL (except when lectin was 
used) (see Table 1 for details). The sections were counter-stained with Hoechst 33258 and mounted in 10% (v/v) 
Mowiol® solution (Polysciences, Eppelheim, Germany). Images of fluorescent sections and whole mounts were 
obtained using an epifluorescence Olympus BX60 microscope connected to a Hamamatsu C11440 digital camera.
Figure 7. IL-6 mRNA and protein expression were increased 4 h and 8 h after PVL injection. The mRNA 
extracted from retinal tissue were analyzed by RT-qPCR. The mRNA (IL-8, TNF-α, VEGF, IL-1β, IL-6) levels 
were normalized by those of β-actin and presented as fold changes relative to control groups. The results ∆Ct 
were analyzed statistically by the paired t-test. Only IL-6 showed significant difference, increasing 11.24 ± 4.123 
folds at 4 h and 13.74 ± 4.457 folds at 8 h after PVL injection (A, *p < 0.05, n = 3 eyes for each group). The proteins 
expression of IL-8, TNF-α, IL-1β, IL-6 were also semi-quantitatively measured by Western blotting. The full-length 
blots are presented in Supplementary Figs S4, 6, 7. Only IL-6 expression significantly increased by 1.85 ± 0.3 folds 
at 4 h and 2.87 ± 0.26 folds at 8 h after PVL injection. The blots of IL-6 and β-actin were from the same samples in 
the same gels with different exposure time (B, *p < 0.05, **p < 0.01, ***p < 0.005 n = 3 eyes for each group).
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Cell counting. Five different microscope fields (266 µm × 266 µm) of vertical retinal sections were captured 
by the camera. The proportions of PVL-positive RGCs and DACs were measured in the RGC layer. PVL-positive 
cells were double-labeled by PVL and cell-specific markers for RGCs and DACs (Figs 1 and 2). The percentages of 
PVL-positive RGCs and DACs in each eye were established after triplicate experiments. For TUNEL positive cells 
count, five different microscope fields were analyzed for each retina.
Western blotting. One half of whole frozen retinas were homogenized by passing through a 26-Gauge needle sev-
eral times in RIPA buffer [1% (v/v) NP-40, 0.1% SDS, 1% (w/v) sodium deoxycholate, 50 mM sodium chloride, 
25 mM Tris-HCl pH 8.0] containing an inhibitor protease cocktail. The concentration of proteins in the supernatant 
was quantified using the BCA kit (660-nm Protein Assay Reagent, Pierce Biotechnology). The same amount of 
protein was loaded in each lane of SDS-PAGE gel (Bio-Rad Laboratories, Hercules, CA, USA). After migration, 
proteins were transferred to a nitrocellulose membrane, which was blocked in 5% (w/v) skimmed milk in PBS and 
probed in primary antibody anti-nitrotyrosine, anti-IL-6, anti-IL-8, anti-TNFα, anti-IL-1β (see Table 1) overnight 
at 4 °C. The membranes were washed three times in phosphate-buffered saline with Tween® (PBST) and incubated 
in Peroxidase-conjugated anti-mouse or anti-rabbit secondary antibodies (see Table 1) for 1 h at room temperature. 
The digital images were developed using ECL Western blotting detection reagent (Bio-Rad Laboratories, Hercules, 
CA, USA) and a chemiluminescence camera (ChemiDoc™ XRS, Bio-Rad). The protein expressions were quantified 
by densitometry analysis of Western Blots bands using BIO-1D software. The tests were triplicate.
Real-time RT-qPCR. We analyzed tested retinas (PVL 4 h and PVL 8 h, 3 eyes for each group) and control 
retinas (PBS 4 h, 6 eyes) using RT-qPCR to see the elevation of cytokines as sign of retinal inflammation. The eyes 
were immediately dissected after the death of rabbit at the end of times course and put into CO2-independent 
medium (Gibco, Life technologies, Carlsbad, USA). The retinas were immediately isolated in CO2-independent 
medium and stocked immediately at −80 °C. Trizol reagent (Sigma, Saint-Louis, USA) was added into tube con-
tained frozen retina, the retinas were passed through 23-Gauge needle then 26-Gauge needle several times to 
homogenize the retina. Total RNA was isolated using Trizol reagent according to the manufacturer’s instruc-
tions. The final RNA solutions were quantified with spectrophotometry (NanoDrop; Thermo Scientific, Waltham, 
USA). Then, 10 µg RNA aliquotes were treated with DNA-free kit DNase treatment (Ambion, Life technologies) 
at 37 °C for 30 min and removal reagents according to manufacturer’s instructions. RNA integrity was analyzed 
using non-denaturing agarose gel electrophoresis. Total RNA was immediately reverse transcribed(RT) using 
Superscript First-Strand Synthesis for RT-PCR (Invitrogen, Life technologies). Diethyl pyrocarbonatedecarbonate 
(DEPC) (Sigma) treated H2O was added to RT mixture (0.5 µl random hexamers (200 ng/ml), 500ng total RNA, 
1 µl NTP) to achieve a 12 µl volume, then incubated at +65 °C for 5 min and placed in glass for 2 min. Then 0.5 µl 
of 0.1 M DDT, 0.5 μl of transcriptase, 4 µl of First Strand buffer, 3 ul of sterile H2O were added to the mixture. Then, 
the total mixture was put into ThermoCycler programmed at +42 °C for 50 min and at +70 °C for 15 min. The 
cDNA was diluted in 3 times with DEPC treated H2O. 5 µl of diluted DNA, 10 µl SYBR mix (LightCycler 480 SYBR 
Green I Master, Roche, Basel, Switzerland), 2 µl of forward and reverse primers, and 3ul H2O were mixed and put 
into 96 wells plate. The plate was placed into Real-Time PCR System (Light Cycler 480, Roche). The primers were 
designed to have Tm around 60 °C by using Primer3 software. PCR was programmed as initial denaturation step at 
+95 °C for 10 min, 45 cycles of amplification (denaturation at +95 °C for 15 s, annealing at +60 °C for 20 s, exten-
sion at +72 °C for 15 s), and melting curve analysis (+60 °C to +95 °C increment at +0.3 °C). The specificity of 
PCR products was verified according to one melting curve peak and one band in agarose gel electrophoresis. RTs 
without reverse transcriptase were used as controls to assure no significant DNA contamination. The sequences 
of primers: β-actin forward primer 5′-gcgggacatcaaggagaag-3′, afterward primer 5′-aggaaggagggctggaaga-3′; IL-6 
forward primer 5′-tcaggccaagttcaggagtg-3′, afterward primer 5′-atgaagtggatcgtggtcgt-3′; IL-8 forward primer 
5′-tggctgtggctctcttgg-3′, afterward primer 5′-atttgggatggaaaggtgtg-3′; TNFα forward primer 5′-cgtagtagca 
aacccgcaag-3′, afterward primer 5′-tgagtgaggagcacgtagga-3′; IL-1β forward primer 5′-ttgtcagtcgttgtggctct-3′, 
afterward primer 5′-ggatttctgttgtgcatcct-3′; VEGF forward primer 5′-cgagaccttggtggacatctt-3′, afterward primer 
5′-tgcattcacatttgttgtgct-3′; MCP-1 forward primer 5′-aacgcttctgtgcctgct-3′, afterward primer 5′-ggacccacttctgcttgg-3′. 
The β-actin was used as reference gene and target genes were normalized using this reference gene. The method ∆Ct 
was used to calculate relative quantification between control retina and tested retina. The fold changes were calcu-
lated using 2−∆∆Ct. The tests were triplicate. The significant changes of every target gene were statistically analyzed 
using ∆Ct paired t-tests.
Statistical analysis. Statistical analysis was performed with GraphPad InStat version 3.10. Statistical sig-
nificance was calculated with one-way ANOVA using the Tukey-Kramer multiple comparisons test and paired 
t-tests. Statistical significance was assumed at p < 0.05.
Data availability. All data sets generated, including those that were analyzed during the current study, are 
available with the corresponding author on request.
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